The Department of Health and Human Services has canceled today’s deadline for hospitals and health systems to submit data to inform the agency’s distribution of its supply of remdesivir. The deadline for submitting data into HHS’s TeleTracking system was supposed to be at 11:59 p.m. ET today.

Late last week, HHS notified hospitals that another round of data were to be collected by midnight tonight to inform the distribution of the remdesivir that Gilead donated to the U.S. Over the weekend, HHS determined that it did not need the additional data at this time. Registered users of the TeleTracking portal received an email announcing the agency’s decision to postpone data collection.

While hospitals do not have to submit the COVID-19 admission and COVID-19 intensive care unit occupancy data to TeleTracking today, HHS has indicated it intends to ask for updated data again in the next few weeks.

The AHA has urged HHS to share a data reporting schedule with hospitals so that their teams know well in advance when the data are due and plan to fulfill the request. 

Related News Articles

Headline
The Department of Veterans Affairs July 8 will host a webinar featuring clinicians who will present a case-based educational session on performing cognitive…
Headline
The Food and Drug Administration Monday authorized the emergency use of the BD (Becton Dickinson) Veritor System for Rapid Detection of SARS-CoV-2. The test…
Headline
The Environmental Protection Agency yesterday approved two Lysol products following testing indicating that both safely and effectively kill the virus that…
Headline
The AHA, Association of American Medical Colleges and Catholic Health Association of the United States today requested the Department of Treasury and the…
Headline
The AHA is hosting calls for all hospital and health system leaders to provide the latest information on and answer questions about the COVID-19 pandemic. The…
Blog
A recent article in the Wall Street Journal about coronavirus infections in hospitals speaks to the spread of this disease and the importance of taking…